Status:
COMPLETED
Using SMART Experimental Design to Personalize Treatment for Child Depression
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Depression
Eligibility:
All Genders
7-14 years
Phase:
NA
Brief Summary
The purpose of the study is: 1. To conduct a pilot SMART (Sequential, Multiple Assignment, Randomized) study with the long-term goal of developing a personalized treatment for child depression. 2. To...
Detailed Description
Child depression is among the most prevalent and impairing pediatric conditions and constitutes a major public health concern. Unfortunately, treatment benefits are relatively modest and short-lived w...
Eligibility Criteria
Inclusion
- Current diagnosis of Major Depressive Disorder (MDD), Dysthymic Disorder (DD), or Depressive Disorder Not Otherwise Specified (NOS).
- If receiving psychiatric medication, dose should be stable for at least three months at enrollment.
Exclusion
- A disorder other than depression as primary diagnosis.
- Autism Spectrum Disorders and Pervasive Developmental Delay or Disorder.
- Mental Retardation.
- Psychotic Disorders and Schizophrenia.
- Mania or Hypomania disorders.
- Acute suicidal behavior and/or acute plan that require higher level of care, and being hospitalized over the past year for a suicide attempt or for threatening to commit suicide.
- Participation in additional psychotherapy.
- Caregiver and/or children do not speak English.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01880814
Start Date
June 1 2013
End Date
November 30 2018
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114